Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Hile Bio-Technology Co's quarterly market cap
declined
from Sep. 2025 (¥4,458.5 Mil) to Dec. 2025 (¥3,999.5 Mil) and
declined
from Dec. 2025 (¥3,999.5 Mil) to Mar. 2026 (¥3,018.3 Mil).
Shanghai Hile Bio-Technology Co's annual market cap
declined
from Dec. 2023 (¥7,046.1 Mil) to Dec. 2024 (¥4,546.1 Mil) and
declined
from Dec. 2024 (¥4,546.1 Mil) to Dec. 2025 (¥3,999.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Hile Bio-Technology Co's Enterprise Value for Today is ¥1,597.8 Mil.
Shanghai Hile Bio-Technology Co (SHSE:603718) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Shanghai Hile Bio-Technology Co Market Cap Related Terms
Shanghai Hile Bio-Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603718 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Shanghai Hile Bio-Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Hile Bio-Technology Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Hile Bio-Technology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Shanghai Hile Bio-Technology Co's Market Cap falls into.
Shanghai Hile Bio-Technology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Hile Bio-Technology Co (SHSE:603718) has a Market Cap of ¥1,877.5 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai Hile Bio-Technology Co and its competitors. According to the industry distribution chart, Shanghai Hile Bio-Technology Co ranks #534 out of 1423 companies in the Biotechnology industry, placing it in the top 37.5%.
Is Shanghai Hile Bio-Technology Co's Market Cap too high?
Shanghai Hile Bio-Technology Co's current Market Cap is ¥1,877.5 Mil. Based on the distribution chart, Shanghai Hile Bio-Technology Co ranks #534 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai Hile Bio-Technology Co has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Hile Bio-Technology Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Hile Bio-Technology Co ranks #534 out of 1423 companies for Market Cap. This puts Shanghai Hile Bio-Technology Co in the upper half of its industry. The industry median Market Cap is 115.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 115.88, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shanghai Hile Bio-Technology Co and its competitors. For the Biotechnology industry, the median Market Cap is 115.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Hile Bio-Technology Co's current Market Cap is ¥1,877.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Hile Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co (SHSE:603718) is currently considered Possible Value Trap. The stock's GF Value™ is ¥4.28, compared to a current price of ¥2.88 — trading 32.7% below its estimated fair value. The current Market Cap is ¥1,877.5 Mil. Shanghai Hile Bio-Technology Co's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shanghai Hile Bio-Technology Co (SHSE:603718), the current Market Cap is ¥1,877.5 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Hile Bio-Technology Co (SHSE:603718) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Hile Bio-Technology Co stock appears to be undervalued.
The current stock price of ¥2.88 is trading 32.7% below its estimated GF Value™ of ¥4.28.
GuruFocus considers Shanghai Hile Bio-Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603718:
Market Cap: ¥1,877.5 Mil
GF Value™: ¥4.28 vs. price of ¥2.88 (32.7% below fair value)
No single metric tells the full story. See the SHSE:603718 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Hile Bio-Technology Co Business Description
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
47GF Score
Get the complete analysis for SHSE:603718
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603718 has been successfully added to your 
